Search results
2024 MLB Draft: Top 50 player rankings
Yahoo Sports· 11 hours agoAfter redshirting as a freshman in Athens in 2022, Condon put himself on the radar as a likely first-round draft pick in 2023, when he hit .386 with 25...
No fooling: Fan Duel fined for taking bets on April Fool's Day on events that happened a week before
Associated Press via Yahoo News· 11 hours agoIt might have seemed too good to be true, but there it was, and on April Fool's Day, no less: One of...
George Clooney calls on Biden to drop out of the 2024 race weeks after co-hosting a Democratic...
Yahoo News· 13 hours agoIn an op-ed published by the New York Times on Wednesday, the Academy Award-winning actor said that...
The Protocol: Side-Dealing Accusations Put Crypto VC Funding in Spotlight
CoinDesk via Yahoo News· 13 hours agoIn this week's blockchain tech newsletter, we're highlighting the firm Polychain's accusation...
More woes for the media industry as CNN to cut 100 jobs
The Independent via Yahoo News· 13 hours agoIn some circles, CNN is seen as behind the curve, with other competitors like NBC, CBS, ABC, and Fox...
Can He Save Paramount? Hollywood Takes a Hard Look at David Ellison’s Mogul Ambitions
Variety via Yahoo News· 14 hours agoLet’s talk about the David of it all. The new chairman and CEO of the soon-to-be-combined Skydance...
Will Q2 Earnings Power Dow ETFs?
Zacks via Yahoo News· 15 hours agoThe Dow Jones is underperforming the other large-cap indices, such as the S&P 500 and Nasdaq Composite Index. Can the
Is Germany set to become the next ‘weed tourism’ hotspot? Some officials hope not
Euronews via Yahoo News· 15 hours agoIs there global support for legalisation in Germany? Germany first took a step towards legalisation...
5 Stocks Worth a Look From Leading Sectors This Earnings Season
Zacks via Yahoo News· 16 hours agoApple (AAPL), HCA Healthcare (HCA), Expro International (XPRO), Churchill Downs (CHDN) and JPMorgan...
Is GSK an Attractive Drug Stock to Add to Your Portfolio Now?
Zacks via Yahoo News· 17 hours agoArexvy sales are expected to be strong in 2024 driven by further penetration in the U.S. market as...
